Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
本文描述了用于抑制TRPC5离子通道及与TRPC5相关的疾病的化合物、组合物和方法。
Substituted xanthines and methods of use thereof
申请人:Hydra Biosciences, Inc.
公开号:US10399982B2
公开(公告)日:2019-09-03
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
描述了用于抑制 TRPC5 离子通道和与 TRPC5 相关疾病的化合物、组合物和方法。
US20140275071A1
申请人:——
公开号:US20140275071A1
公开(公告)日:2014-09-18
Substituted Xanthines and Methods of Use Thereof
申请人:Hydra Biosciences, Inc.
公开号:US20170305910A1
公开(公告)日:2017-10-26
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
TRPC ION CHANNEL INHIBITORS FOR USE IN THERAPY
申请人:UNIVERSITY OF LEEDS
公开号:US20200345741A1
公开(公告)日:2020-11-05
Described herein are inhibitors Transient Receptor Potential Canonical (TRPC) ion channels comprising TRPC4 protein and/or TRPC5 protein for use in combating obesity and other medical conditions including insulin resistance associated with Type II diabetes or development of Type II diabetes (pre-diabetes), metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Also disclosed is the use of the inhibitors for cosmetic purposes, such as cosmetic weight loss.